Since 2012, the percentage of FFP distributed to the private hospitals has been 72% qFFP and 28% PRT-treated FFP (FFP treated with riboflavin and UV light; Mirasol PRT system). to the private hospitals was 60/40. During 2012 and 2013, there have been no FFP transfusion-related TRALI instances, when the proportion Mcl1-IN-9 of male/female FFP distributed to the private hospitals was around 97/3. Mirasol PRT allows quick availability (24 h from collection) compared to quarantined FFP (3 months from collection). Summary Thanks to its readiness, simplicity and feasibility, riboflavin- and UV light-treated FFP implementation can facilitate the preferential use of FFP from male donors like a TRALI prevention strategy. strong class=”kwd-title” Keywords: Riboflavin, UV light, Plasma, TRALI Intro The Mirasol Pathogen Reduction Technology? (PRT) system for platelets (PLTs) and plasma uses riboflavin and UV light in order to oxidize nucleic acids (DNA or RNA) through electron transfer reactions, resulting in the inhibition of pathogen genome and leukocyte replication which leads to inactivation [1, 2]. Since riboflavin is an essential nutritive ingredient that is normally present in the body and as its photo-products are non-toxic, there is no need for his or her removal from inactivated blood parts [3, 4]. Since 1995, the Balearic Islands Blood Bank (BIBB) offers maintained a fresh freezing plasma (FFP) quarantine system to provide plasma for transfusion therapy of individuals within our community. Basically, the system consists in liberating the plasma unit once a donor has been retested by NAT for HIV, HBV HCV, with bad results after a period of at least 3 months . In 2011, the National Committee for Blood Safety founded a recommendation for the preferential use of male donors to provide FFP as a strategy to prevent transfusion-related acute lung injury (TRALI). Selecting FFP from male donors to be quarantined is a very complex process due to multiple manual methods in the quarantine system. In addition, the plasma models are usually unavailable for issue for at least 3 months. As a result, in 2012, the BIBB initiated the routine use of FFP derived from whole blood donations prepared using riboflavin and UV light for the transfusion support of individuals with congenital and acquired coagulopathies. However, the quarantine system for plasmapheresis donations was still managed to provide plasma transfusion support to individuals with thrombotic thrombocytopenic purpura (TTP) since the superior effectiveness of quarantined FFP (qFFP) compared to inactivated plasma offers previously been shown for TTP treatment, and specifically with plasma treated with methylene blue [6, 7]. Another important reason for selecting riboflavin and UV light PRT for FFP was that this technology can also be applied to PLTs. In fact, we have recently implemented riboflavin and UV light PRT for PLTs. This study presents TRALI annual incidence in our region related to the use of riboflavin- and UV light-treated FFP from 2012 to 2013, and compares the results with those of the period from 2010 to 2011 prior to the intro of riboflavin and UV light technology for FFP in our community. Material and Methods Hemovigilance Data Collection The BIBB collects and materials all blood parts for 15 general public and private hospitals, which completely provide more than 3,500 mattresses in a region with a populace of about 1 million inhabitants. The BIBB performs approximately 42,000 whole-blood and 5,000 PLT component selections per year to support transfusion therapy for varied individual populations, including those cared for by hematology-oncology and cardiovascular surgery professionals. Around 12,530 l of plasma are acquired after fractionation: 11,102 l (88.6%) are used by the Mcl1-IN-9 plasma fractionation market to make albumin and immunoglobulins and 1,428 l (11.4%) are destined for transfusion. The Balearic Island Hemovigilance Division (BIHVD) located in the BIBB facility, one of the 17 regional hemovigilance divisions in the Spanish Hemovigilance Network, collects and analyses all severe transfusion events reported from the Balearic Island Medical Centers. The BIHVD represents the autonomic level of the Spanish Hemovigilance Network in our region; therefore, it is CAB39L definitely responsible for communications between the Community Medical Centers and the Spanish Ministry of Health. While maintaining patient confidentiality, information concerning severe transfusion event event in our community was from the BIHVD database. The BIHVD system as well as the Spanish Hemovigilance Network meet the requirement of the Western Directive 2005/61/EC on Hemovigilance  and are based on an anonymous, voluntary, non-punitive serious adverse events reporting system. The annual incidence of TRALI from 2010 to 2013 was from Mcl1-IN-9 the BIHVD database. Preparation of Blood Components Plasma Parts Quarantine FFP Since 1995, FFP models derived from.